Literature DB >> 11482501

Renal replacement therapy: physical properties of hollow fibers influence efficiency.

H D Düngen1, C von Heymann, C Ronco, W J Kox, C D Spies.   

Abstract

INTRODUCTION: Physical properties of filters for continous renal replacement therapy have a great impact on biocompatibility. According to Poiseuille's law, a filter with more and shorter hollow fibers should offer a decreased pressure drop and, therefore, lower transmembrane pressure (TMP). The aim of this study was to study the effect of a new filter configuration in terms of TMP and clotting compared with the standard configuration.
METHODS: In a prospective randomized cross-over study 2 polysulphone hollow fiber hemofilters, one handmade, which differed only in length and number of hollow fibers were compared. In each group 12 filters were investigated during continous venovenous hemofiltration in patients with acute renal failure due to septic shock. Pressures were measured every 3 hours and running time until filter clotting was documented. Mediators before and after the filter, at the end of treatment and in filtrate were assessed.
RESULTS: The standard filter with longer hollow fibers had significantly lower TMPs (106 vs. 194 mmHg, p=0.02) and longer running times (1276 vs. 851 min, p=0.04). There were no differences in hematocrit, total protein, cellular and plasmatic coagulation or blood temperature. No significant elimination of mediators was shown.
CONCLUSION: In contrast to our expectations, the filter with the longer hollow fibers had a better performance, as it ran longer and had lower TMP This may be due to slower blood flow leading to an increase in blood viscosity in a filter with a larger cross section.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11482501

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  6 in total

1.  Adsorption of amikacin, a significant mechanism of elimination by hemofiltration.

Authors:  Qi Tian; Charles D Gomersall; Margaret Ip; Perpetua E Tan; Gavin M Joynt; Gordon Y S Choi
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

Review 2.  Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.

Authors:  Yasushi Tsujimoto; Sho Miki; Hiroki Shimada; Hiraku Tsujimoto; Hideto Yasuda; Yuki Kataoka; Tomoko Fujii
Journal:  Cochrane Database Syst Rev       Date:  2021-09-14

Review 3.  Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

Authors:  A M Macleod; M Campbell; J D Cody; C Daly; C Donaldson; A Grant; I Khan; K S Rabindranath; L Vale; S Wallace
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

4.  Platelet Consumption and Filter Clotting Using Two Different Membrane Sizes during Continuous Venovenous Haemodiafiltration in the Intensive Care Unit.

Authors:  Francesca Bonassin Tempesta; Alain Rudiger; Marco Previsdomini; Marco Maggiorini
Journal:  Crit Care Res Pract       Date:  2014-04-27

5.  Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study.

Authors:  Jimena del Castillo; Jesús López-Herce; Elena Cidoncha; Javier Urbano; Santiago Mencía; Maria J Santiago; Jose M Bellón
Journal:  Crit Care       Date:  2008-07-25       Impact factor: 9.097

Review 6.  Clinical review: Patency of the circuit in continuous renal replacement therapy.

Authors:  Michael Joannidis; Heleen M Oudemans-van Straaten
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.